Basal Insulin in Vulnerable Patients
with Type 2 Diabetes
Webcast CME Disclosure
Please read this notice and click the acknowledgement
at the bottom of the page to continue.
Estimated Time to Complete Educational Activity
In this web-based program, physicians and optometrists will learn how recent developments have helped to advance the management of Type 2 diabetes.
December 15, 2017
December 15, 2019
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period December 15, 2017 through December 15, 2019 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 9 segments totaling 2.5 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out your CME certificate.
Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Supported by an educational grant from Sanofi Diabetes
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School and CMEducation Resources, LLC. ‘The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
University of Massachusetts Medical School designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty & Provider Disclosure
University of Massachusetts Medical School requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to University of Massachusetts Medical School policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Program Faculty and Disclosure
VIVIAN A. FONSECA, MD, FRCP
Professor of Medicine and Pharmacology
Tulis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA
Research Support (To Tulane): Grants from Asahi, Bayer
Consulting and Speaking: Takeda, Novo Nordisk, Sanofi-aventis, Eli Lilly, Astra-Zeneca, Janssen
. FRIAS, MD, FACE
Clinical Assistant Professor of Medicine
University of California
National Research Institute
Los, Angeles, California
Consulting: Astra Zeneca, BMS, Johnson and Johnson, Novo Nordisk, Sanofi
Speaker’s Bureau: Sanofi, Eli Lilly, Novo Nordisk, Astra Zeneca
Contracted Research: AbbVie, AstraZeneca, Boehringer Ingelheim, BMS, Elcelyx, Eli Lilly, IONIS, Janssen, Johnson and Johnson, Ligand, Merck, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi, Theracos, vTv
GUILLERMO E. UMPIERREZ, MD, CDE
Professor of Medicine
Emory University School of Medicine
Emory University Hospital/Grady Health System
Nothing to disclose
PABLO F. MORA, MD, MSc, FACE, CDE
Adjunct Associate Professor
University of Texas Southwestern Medical Center at Dallas
Diabetes America (Plano)
Consultant and Speaker’s Bureau: Novo Nordisk
Upon completion of this activity, participants will be able to:
- Apply national guidelines, including the non-strictly algorithmic and flexibly prescriptive 2012 ADA/ EASD Guidelines focused on comprehensive management of diabetes; and identify therapeutic options, based on objective triggers—number and type of OADs, patient needs and preferences, target goal attainment, and other factors—consisting of oral, basal insulin-, and/or combined oral-insulin regimens that provide guideline-consistent care for this population.
- Explain the physiologic basis of long-acting insulin formulations and how mimicking physiologic insulin triggers and time-activity profiles may improve efficacy and safety of long-acting formulations;
- Identify patients with T2D who are not meeting target goals for HbA1 and/or other targets require initiation with or who require intensification with basal insulin therapy;
- Assess and calculate the risks of hypoglycemia in their patients with T2D, counsel their patients on recognizing symptoms of hypoglycemia, and select among therapeutic agents, including established and longer-acting basal insulin-based therapies and combination oral-insulin-based treatments that may reduce the risk of hypoglycemia in this patient subgroup;
- Understand how new basal insulin formulations in development or recently introduced into clinical use may help reduce the risk of hypoglycemia associated with insulin use;
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
- We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
- For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
- We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
- If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
Copyright © 2017 by CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.
||I have read
this CME information statement and wish to participate in this CME
Copyright © CMEducation Resources, LLC